Howard W. Robin
Net Worth

Last updated:

What is Howard W. Robin net worth?

The estimated net worth of Mr. Howard W. Robin is at least $79,758,285 as of 18 Dec 2024. He owns shares worth $29,721,663 as insider, has earned $9,716,622 from insider trading and has received compensation worth at least $40,320,000 in Nektar Therapeutics.

What is the salary of Howard W. Robin?

Mr. Howard W. Robin salary is $2,240,000 per year as Chief Executive Officer, Pres & Director in Nektar Therapeutics.

How old is Howard W. Robin?

Mr. Howard W. Robin is 72 years old, born in 1953.

What stocks does Howard W. Robin currently own?

As insider, Mr. Howard W. Robin owns shares in one company:

Company Title Shares Price per share Total value
Nektar Therapeutics (NKTR) Chief Executive Officer, Pres & Director 1,110,675 $26.76 $29,721,663

What does Nektar Therapeutics do?

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and adjuvant melanoma; phase 2 clinical trial for the treatment of renal cell carcinoma, non-small cell lung cancer, and urothelial cancer; phase 1/2A clinical trial to treat squamous cell carcinoma of the head and neck; phase 1/2 clinical trial for the treatment of solid tumors; and phase 1B clinical trial to treat COVID-19. It is also developing NKTR-358, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 1B clinical trial to treat atopic dermatitis and psoriasis; NKTR-255, an IL-15 receptor agonist, which is in phase 1/2 clinical trial for the treatment of non-Hodgkin's lymphoma and multiple myeloma, and head and neck cancer and colorectal cancer; and NKTR-262, a toll-like receptor agonist that is in phase 1/2 clinical trial to treat solid tumors, as well as various other drug candidates. The company has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Baxalta Incorporated; Eli Lilly and Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. Nektar Therapeutics was incorporated in 1990 and is headquartered in San Francisco, California.

NKTR logo
NKTR
Nektar Therapeutics
$26.76

Howard W. Robin insider trading

Nektar Therapeutics

Mr. Howard W. Robin has made 80 insider trades between 2007-2024, according to the Form 4 filled with the SEC. Most recently he sold 85,035 units of NKTR stock worth $84,185 on 18 Dec 2024.

The largest trade he's ever made was exercising 467,200 units of NKTR stock on 25 Nov 2014. As of 18 Dec 2024 he still owns at least 1,110,675 units of NKTR stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 85,035 $0.99 $84,185
Sale
Common Stock 46,995 $1.01 $47,465
Sale
Common Stock 16,278 $1.01 $16,441
Sale
Common Stock 14,881 $1.28 $19,048
Sale
Common Stock 16,650 $1.75 $29,138
Sale
Common Stock 20,033 $0.68 $13,622
Sale
Common Stock 19,877 $0.49 $9,740
Sale
Common Stock 19,998 $0.78 $15,598
Sale
Common Stock 20,361 $0.72 $14,660
Sale
Common Stock 19,635 $3 $58,905
Sale
Common Stock 38,014 $3.57 $135,710
Sale
Common Stock 13,759 $4.76 $65,493
Sale
Common Stock 36,529 $3.95 $144,290
Sale
Common Stock 12,480 $10.95 $136,656
Sale
Common Stock 42,773 $13.16 $562,893
Sale
Common Stock 11,515 $13.83 $159,252
Sale
Common Stock 11,560 $18.3 $211,548
Sale
Common Stock 11,495 $22.37 $257,143
Option
Stock Option 150,000 $8.8 $1,320,000
Option
Common Stock 150,000 N/A N/A
Sale
Common Stock 150,000 N/A N/A
Option
Stock Option 150,000 $8.8 $1,320,000
Option
Common Stock 150,000 $4.4 $660,000
Sale
Common Stock 150,000 $8.8 $1,320,000
Option
Common Stock 150,000 $8.8 $1,320,000
Sale
Common Stock 150,000 $20.71 $3,106,050
Option
Stock Option 150,000 N/A N/A
Option
Common Stock 150,000 N/A N/A
Sale
Common Stock 150,000 $20.71 $3,106,050
Sale
Common Stock 11,975 $16.93 $202,737
Sale
Common Stock 11,885 N/A N/A
Sale
Common Stock 8,968 N/A N/A
Sale
Common Stock 8,448 N/A N/A
Sale
Common Stock 13,556 N/A N/A
Option
Common Stock 33,333 N/A N/A
Option
Stock Option 33,333 N/A N/A
Sale
Common Stock 33,333 N/A N/A
Sale
Common Stock 33,334 N/A N/A
Option
Stock Option 33,334 N/A N/A
Option
Common Stock 33,334 N/A N/A
Option
Common Stock 33,333 N/A N/A
Sale
Common Stock 33,333 N/A N/A
Option
Stock Option 33,333 N/A N/A
Option
Common Stock 60,000 $16.31 $978,600
Option
Common Stock 60,000 N/A N/A
Sale
Common Stock 12,551 N/A N/A
Option
Common Stock 66,666 $7.21 $480,662
Sale
Common Stock 33,333 N/A N/A
Option
Common Stock 66,666 N/A N/A
Sale
Common Stock 33,334 N/A N/A
Option
Common Stock 66,668 $32.11 $2,140,709
Option
Common Stock 66,668 N/A N/A
Sale
Common Stock 33,333 N/A N/A
Option
Common Stock 33,333 $7.21 $240,331
Option
Common Stock 66,666 N/A N/A
Sale
Common Stock 33,333 N/A N/A
Option
Common Stock 66,666 $7.21 $480,662
Option
Common Stock 66,666 N/A N/A
Option
Common Stock 33,334 $33.38 $1,112,689
Option
Common Stock 66,668 N/A N/A
Sale
Common Stock 33,334 N/A N/A
Option
Common Stock 33,333 $7.21 $240,331
Option
Common Stock 66,666 N/A N/A
Sale
Common Stock 33,333 N/A N/A
Sale
Common Stock 13,383 N/A N/A
Option
Common Stock 66,666 $7.21 $480,662
Option
Common Stock 66,666 N/A N/A
Sale
Common Stock 33,333 N/A N/A
Sale
Common Stock 33,334 N/A N/A
Option
Common Stock 66,668 $43.2 $2,880,058
Option
Common Stock 66,668 N/A N/A
Option
Common Stock 33,333 $7.21 $240,331
Option
Common Stock 66,666 N/A N/A
Sale
Common Stock 42,215 N/A N/A
Sale
Common Stock 15,326 N/A N/A
Option
Stock Option 40,000 N/A N/A
Option
Stock Option 43,333 N/A N/A
Option
Common Stock 43,333 N/A N/A
Sale
Common Stock 43,333 N/A N/A
Sale
Common Stock 43,333 N/A N/A
Option
Common Stock 43,333 N/A N/A
Option
Stock Option 43,333 N/A N/A
Sale
Common Stock 43,334 N/A N/A
Option
Common Stock 43,334 N/A N/A
Option
Stock Option 43,334 N/A N/A
Sale
Common Stock 12,791 N/A N/A
Sale
Common Stock 43,333 N/A N/A
Option
Common Stock 43,333 N/A N/A
Option
Stock Option 43,333 N/A N/A
Option
Common Stock 43,333 N/A N/A
Option
Stock Option 43,333 N/A N/A
Sale
Common Stock 43,333 N/A N/A
Sale
Common Stock 43,334 N/A N/A
Option
Common Stock 43,334 N/A N/A
Option
Stock Option 43,334 N/A N/A
Sale
Common Stock 12,788 N/A N/A
Option
Stock Option 83,333 N/A N/A
Sale
Common Stock 83,333 N/A N/A
Option
Common Stock 83,333 N/A N/A
Sale
Common Stock 83,333 N/A N/A
Option
Common Stock 83,333 N/A N/A
Option
Stock Option 83,333 N/A N/A
Option
Stock Option 83,334 N/A N/A
Option
Common Stock 83,334 N/A N/A
Sale
Common Stock 83,334 N/A N/A
Sale
Common Stock 83,333 N/A N/A
Option
Stock Option 83,333 N/A N/A
Option
Common Stock 83,333 N/A N/A
Option
Common Stock 83,333 N/A N/A
Sale
Common Stock 83,333 N/A N/A
Option
Stock Option 83,333 N/A N/A
Sale
Common Stock 8,380 N/A N/A
Option
Common Stock 83,334 N/A N/A
Option
Stock Option 83,334 N/A N/A
Sale
Common Stock 8,388 N/A N/A
Sale
Common Stock 8,636 N/A N/A
Sale
Common Stock 87,500 N/A N/A
Option
Stock Option 87,500 N/A N/A
Option
Common Stock 87,500 N/A N/A
Sale
Common Stock 87,500 N/A N/A
Option
Stock Option 87,500 N/A N/A
Option
Common Stock 87,500 N/A N/A
Option
Stock Option 87,500 N/A N/A
Option
Common Stock 87,500 N/A N/A
Sale
Common Stock 87,500 N/A N/A
Option
Common Stock 87,500 N/A N/A
Option
Stock Option 87,500 N/A N/A
Sale
Common Stock 87,500 N/A N/A
Sale
Common Stock 5,958 N/A N/A
Option
Stock Option 87,500 N/A N/A
Sale
Common Stock 87,500 N/A N/A
Option
Common Stock 87,500 N/A N/A
Option
Stock Option 87,500 N/A N/A
Sale
Common Stock 87,500 N/A N/A
Option
Common Stock 87,500 N/A N/A
Sale
Common Stock 11,817 N/A N/A
Sale
Common Stock 2,170 N/A N/A
Option
Common Stock 5,625 N/A N/A
Sale
Common Stock 2,147 N/A N/A
Option
Common Stock 5,625 N/A N/A
Option
Stock Option 66,666 N/A N/A
Sale
Common Stock 66,666 N/A N/A
Option
Common Stock 66,666 N/A N/A
Option
Stock Option 66,667 N/A N/A
Option
Common Stock 66,667 N/A N/A
Sale
Common Stock 66,667 N/A N/A
Option
Stock Option 125,001 N/A N/A
Sale
Common Stock 125,001 N/A N/A
Option
Common Stock 125,001 N/A N/A
Option
Stock Option 125,000 N/A N/A
Sale
Common Stock 125,000 N/A N/A
Option
Common Stock 125,000 N/A N/A
Option
Stock Option 125,000 N/A N/A
Sale
Common Stock 125,000 N/A N/A
Option
Common Stock 125,000 N/A N/A
Option
Common Stock 124,999 N/A N/A
Sale
Common Stock 124,999 N/A N/A
Option
Common Stock 124,999 $6.72 $839,993
Option
Stock Option 124,999 N/A N/A
Option
Common Stock 58,333 N/A N/A
Sale
Common Stock 58,333 N/A N/A
Option
Stock Option 58,333 N/A N/A
Sale
Common Stock 58,334 N/A N/A
Option
Stock Option 58,334 N/A N/A
Option
Common Stock 58,334 N/A N/A
Option
Common Stock 209,056 N/A N/A
Option
Stock Option 209,056 N/A N/A
Sale
Common Stock 209,056 N/A N/A
Option
Common Stock 140,944 N/A N/A
Sale
Common Stock 140,944 N/A N/A
Option
Stock Option 140,944 N/A N/A
Option
Stock Option 467,200 N/A N/A
Sale
Common Stock 467,200 N/A N/A
Option
Common Stock 467,200 N/A N/A
Option
Stock Option 132,800 N/A N/A
Option
Common Stock 132,800 N/A N/A
Sale
Common Stock 132,800 N/A N/A
Purchase
Common Stock 10,000 $11.27 $112,700